Oric Pharmaceuticals, Inc. — Director's Dealing 2021

Sep 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Oric Pharmaceuticals, Inc. (ORIC)
CIK: 0001796280
Period of Report: 2021-09-07

Reporting Person: Chacko Jacob (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-07	Common Stock	S	5981	$25.1084	Disposed	16751	Direct
2021-09-08	Common Stock	S	200	$25.035	Disposed	16551	Direct

Footnotes

F1: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2: Represents the weighted average share price of an aggregate total of 5,981 shares sold in the price range of $25.00 to $25.295 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Represents the weighted average share price of an aggregate total of 200 shares sold in the price range of $25.00 to $25.07 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.